SHINE Technologies has entered into a definitive agreement to acquire the SPECT business from Lantheus, a radiopharmaceutical-focused company, the company announced recently. Lantheus’ SPECT product portfolio includes imaging agents for…
SHINE Technologies and Modawina Medical Company (MMC) have entered a strategic distribution partnership to bring Ilumira, SHINE’s non-carrier-added lutetium-177, to patients in the United Arab Emirates, the company announced recently….
SHINE Technologies is partnering with Sumitomo Corporation of Americas (SCOA), a leading global trading and investment company, the company announced today. According to a release, the partnership, formalized through a…
SHINE Technologies has been selected to provide a 14 mega electron volt deuterium-tritium fusion system to the U.K. Atomic Energy Authority (UKAEA)’s Lithium Breeding Tritium Innovation (LIBRTI) program in 2027,…
SHINE Technologies has partnered with Antelope Surgical Solutions, a biotech company pioneering next-generation multimodal radiopharmaceuticals, the company announced recently. According to a release, the supply agreement will accelerate Antelope’s clinical…
SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
SHINE Technologies and WARF Therapeutics today announced pre-clinical research results from collaborative efforts with the Advanced Radiotheranostics Lab at the University of Wisconsin. According to a release, the studies showed…
SHINE Technologies was awarded another Department of Energy’s Small Business Innovation Research Grant to help transform DOE-supported science and technology breakthroughs into viable products and services, creating a bridge between…
SHINE Technologies announced recently that it is entering into a supply agreement with GlyTherix Ltd, an Australian targeted-radiotherapy company specializing in developing antibody radiopharmaceuticals for solid tumors. According to a…
SHINE Technologies was awarded $32 million from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the organization announced today. According to a release, the funds will aid in the…
